archiveANSS

RayzeBio , the radiopharmaceutical therapeutics company, rose 101% to $61.40 after reaching an agreement to be acquired by Bristol Myers...

Nike reported fiscal second-quarter earnings that beat analysts’ expectations but announced a $2 billion cost-cutting plan over the next three...